VB19055

· Zhejiang Yangli Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VB19055, covering 2025-11-28 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population [Phase 1]